The First Private Hospital in Northern Greece to receive certification in accordance with European Standard EN 15224:2017
The official certification body TÜV AUSTRIA Hellas certified GENESIS as the First Private Hospital in Northern Greece to do so successfully and in accordance with European Standard EN 15224:2017.
It is an official European specification for the provision of health services, with a primary focus on efficient patient safety-related risk management; it includes best practices and internationally recognized tools that, when combined, form the most efficient method for achieving:
- Effective quality management of patient care-associated risks and healthcare services offered by medical institutions
- Implementation of quality control (QC) for all medical institutions
- Evaluation of Clinical Efficacy and ongoing Clinical Performance improvement
- Continuous Professional Development for all healthcare processionals.
- Ensuring patient safety
Scope:
Offering Primary and Secondary Healthcare Services.
GENESIS certification according to International Standard ISO 9001:2015
TÜV AUSTRIA Hellas, the official certification body, has granted GENESIS full certification in accordance with the International Quality Standard ISO 9001:2015.
Scope:
Offering Primary and Secondary Healthcare Services.
GENESIS certification according to International Standard ISO 14001:2015
Applies an Environmental Management System in line with the above Standard for the following Scope Provision of Primary and Secondary Healthcare Services.
GENESIS certification for laboratories according to the international standard ISO 15189:2022
The clinical laboratory of GENESIS Hospital has been accredited by the Hellenic Accreditation System (E.S.Y.D.) under the terms of the ELOT EN ISO 15189:2022 standard and the ESYD Criteria, to carry out tests as specified in the following Scope of the Accreditation:
- Immunochemical Testing through the analyzer BRAHMS CRYPTOR, for the determination in the blood serum the parameters Free-b-hCG and Pregnancy associated plasma protein (PAPP-A). These measurements are combined with the Nuchal Translucency (NT) Ultrasound during the 1st trimester of pregnancy to determine the risk for chromosomal defects.
- Molecular Testing through the Analyzer PLUSLIFE, for the Determination in the nasal swab of the Qualitative molecular detection of SARS-CoV-2 coronavirus RNA.
GENESIS certification from FACT
Genesis Hospital has been accredited by the “Foundation for the Accreditation of Cellular Therapy (FACT)”, in collaboration with the Public Stem Cell Bank of Papanikolaou Hospital in Thessaloniki related with the receipt and collection of umbilical cord blood (Stem Cells). This certification is the result of an already valuable partnership between GENESIS and the Public Stem Cell Bank and another addition to the Hospital’s Quality Management System.